Login
Create An Account
Login
Create An Account
Search
View All
View All
All Categories
Critical Care, Anaesthetics & Emergency Medicine
Gerontology, Lifestyle Disease & Healthy Aging
Infectious Diseases, Vaccines & Antimicrobials
Ophthalmology
Paediatrics & Neonatology
Healthcare Alerts
Disease Outbreak Resources »
Cholera Outbreak Resources & Updates
The Medical Week in Review | Archive
Terms and Conditions of Use
What's the Diagnosis
Home
Contact Us
Search
Reset
Novel Drugs & Emergent Therapeutics | Paediatrics & Neontatology | Archive 2024
View Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2023
View Paediatrics & Neonatology | Novel Drugs & Emergent Therapeutics Archive 2024
Currently reading
Paediatrics & Neontalogy | Novel Drugs & Emergent Therapeutics Archive 2024
Date
Source
Keywords
Company
Drug
Title & Link
4 April 2024
FDA
CAP, RTI
Basilea Pharmaceutica International
Zevtera (ceftobiprole medocaril sodium)
FDA Approves New Antibiotic for Three Different Uses
8 April 2024
FDA
HIV, Virology
ViiV
DOVATO (DOLUTEGRAVIR/LAMIVUDINE)
FDA Approves DOVATO (DOLUTEGRAVIR/LAMIVUDINE) for Adolescents living with HIV
12 March 2024
FDA
Duchennes, Rare Diseases
Italfarmaco
Duvyzat (givinostat)
.FDA awards Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy
Rate
Viewed
Bookmark
Print
Rating
Rating Value
Most Viewed Articles
All That Remains: A Renowned Forensic Scientist on Death, Mortality, and Solving Crimes
Nov 17, 2023
MNG004-World Health Organisation requests information from China regarding outbreak of respiratory diseases
Nov 23, 2023
CDC Flags BA.2.86 COVID Variant
Dec 04, 2023
Rate This Media
×
1
2
3
4
5
Home
Contact Us
Log in
Powered by eLecture, a VisualLive Solution
© Copyright 2024
Terms of Use
Disclaimer
We use cookies to track how our site is used, but do not store any personal data. For more information, please review our Terms and Conditions.
I agree